Literature DB >> 34339006

The network map of Elabela signaling pathway in physiological and pathological conditions.

Shobha Dagamajalu1, D A B Rex2, G P Suchitha2, Akhila B Rai2, Jan K Rainey3, T S Keshava Prasad4.   

Abstract

Elabela (ELA; also called Apela and Toddler) is one of the recently discovered ligand among the two endogenous peptide ligands (Apelin and Elabela) of the apelin receptor (APLNR, also known as APJ). Elabela-induced signaling plays a crucial role in diverse biological processes, including formation of the embryonic cardiovascular system and early placental development by reducing the chances of occurrence of preeclampsia during pregnancy. It also plays the major role in the renoprotection by reducing kidney injury and the inflammatory response and regulation of gene expression associated with heart failure and fibrosis. Elabela may be processed into different active peptides, each of which binds to APLNR and predominantly activates the signals through PI3K/AKT pathway. Owing to its biomedical importance, we developed a consolidated signaling map of Elabela, in accordance with the NetPath criteria. The presented Elabela signaling map comprises 12 activation/inhibition events, 15 catalysis events, 1 molecular association, 34 gene regulation events and 32 protein expression events. The Elabela signaling pathway map is freely made available through the WikiPathways Database ( https://www.wikipathways.org/index.php/Pathway:WP5100 ).
© 2021. The International CCN Society.

Entities:  

Keywords:  Cardiovascular development; Gastrulation; Preeclampsia; Signaling pathways; WikiPathways

Year:  2021        PMID: 34339006      PMCID: PMC8688647          DOI: 10.1007/s12079-021-00640-4

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  40 in total

1.  Signaling network of Oncostatin M pathway.

Authors:  Gourav Dey; Aneesha Radhakrishnan; Nazia Syed; Joji Kurian Thomas; Arpitha Nadig; Kotteazeth Srikumar; Premendu Prakash Mathur; Akhilesh Pandey; Sze-Kwan Lin; Rajesh Raju; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2012-12-20       Impact factor: 5.782

2.  A network map of endothelin mediated signaling pathway.

Authors:  Shobha Dagamajalu; D A B Rex; Lathika Gopalakrishnan; Gayathree Karthikkeyan; Sumrati Gurtoo; Prashant Kumar Modi; Varshasnata Mohanty; M Mujeeburahiman; Sowmya Soman; Rajesh Raju; Vinod Tiwari; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2020-09-11       Impact factor: 5.782

3.  A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11.

Authors:  B F O'Dowd; M Heiber; A Chan; H H Heng; L C Tsui; J L Kennedy; X Shi; A Petronis; S R George; T Nguyen
Journal:  Gene       Date:  1993-12-22       Impact factor: 3.688

4.  ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ.

Authors:  Lu Zhou; Hang Sun; Ran Cheng; Xiujun Fan; Shanshan Lai; Cheng Deng
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-03-12       Impact factor: 4.310

5.  Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart.

Authors:  Ábel Perjés; Teemu Kilpiö; Johanna Ulvila; Johanna Magga; Tarja Alakoski; Zoltán Szabó; Laura Vainio; Eveliina Halmetoja; Olli Vuolteenaho; Ulla Petäjä-Repo; István Szokodi; Risto Kerkelä
Journal:  Basic Res Cardiol       Date:  2015-11-26       Impact factor: 17.165

6.  The mechanosensitive APJ internalization via clathrin-mediated endocytosis: A new molecular mechanism of cardiac hypertrophy.

Authors:  Lu He; Linxi Chen; Lanfang Li
Journal:  Med Hypotheses       Date:  2016-02-27       Impact factor: 1.538

7.  Central action of ELABELA reduces food intake and activates arginine vasopressin and corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus.

Authors:  Putra Santoso; Yuko Maejima; Kensuke Kumamoto; Seiichi Takenoshita; Kenju Shimomura
Journal:  Neuroreport       Date:  2015-09-30       Impact factor: 1.837

8.  ELA/APELA precursor cleaved by furin displays tumor suppressor function in renal cell carcinoma through mTORC1 activation.

Authors:  Fabienne Soulet; Clement Bodineau; Katarzyna B Hooks; Jean Descarpentrie; Isabel Alves; Marielle Dubreuil; Amandine Mouchard; Malaurie Eugenie; Jean-Luc Hoepffner; Jose J López; Juan A Rosado; Isabelle Soubeyran; Mercedes Tomé; Raúl V Durán; Macha Nikolski; Bruno O Villoutreix; Serge Evrard; Geraldine Siegfried; Abdel-Majid Khatib
Journal:  JCI Insight       Date:  2020-07-23

9.  A comprehensive manually curated reaction map of RANKL/RANK-signaling pathway.

Authors:  Rajesh Raju; Lavanya Balakrishnan; Vishalakshi Nanjappa; Mitali Bhattacharjee; Derese Getnet; Babylakshmi Muthusamy; Joji Kurian Thomas; Jyoti Sharma; B Abdul Rahiman; H C Harsha; Subramanian Shankar; T S Keshava Prasad; S Sujatha Mohan; Gary D Bader; Mohan R Wani; Akhilesh Pandey
Journal:  Database (Oxford)       Date:  2011-07-08       Impact factor: 3.451

View more
  4 in total

1.  The network map of urotensin-II mediated signaling pathway in physiological and pathological conditions.

Authors:  D A B Rex; G P Suchitha; Akhina Palollathil; Anagha Kanichery; T S Keshava Prasad; Shobha Dagamajalu
Journal:  J Cell Commun Signal       Date:  2022-02-16       Impact factor: 5.782

2.  Structural insight into apelin receptor-G protein stoichiometry.

Authors:  Yang Yue; Lier Liu; Li-Jie Wu; Yiran Wu; Ling Wang; Fei Li; Junlin Liu; Gye-Won Han; Bo Chen; Xi Lin; Rebecca L Brouillette; Émile Breault; Jean-Michel Longpré; Songting Shi; Hui Lei; Philippe Sarret; Raymond C Stevens; Michael A Hanson; Fei Xu
Journal:  Nat Struct Mol Biol       Date:  2022-07-11       Impact factor: 18.361

3.  ERK/HIF-1α/VEGF pathway: a molecular target of ELABELA (ELA) peptide for attenuating cardiac ischemia-reperfusion injury in rats by promoting angiogenesis.

Authors:  Kamran Rakhshan; Masoomeh Sharifi; Fatemeh Ramezani; Yaser Azizi; Nahid Aboutaleb
Journal:  Mol Biol Rep       Date:  2022-09-21       Impact factor: 2.742

4.  Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis.

Authors:  Shunyun Xie; Feng Xu; Yue Lu; Yixian Zhang; Xinyang Li; Mengyuan Yu; Wenpeng Cui
Journal:  Front Pharmacol       Date:  2022-06-21       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.